About Our Partners

Mary Crowley Cancer Research Centers

Caliber Biotherapeutics has a strategic alignment with the Mary Crowley Cancer Research Center in Dallas, Texas for rapid development and entry into clinical phase investigations for therapeutic proteins and vaccines products in the cancer therapies.

The mission of Mary Crowley Cancer Research Centers is to expand treatment options for all cancer patients through investigational vaccine, gene and cellular therapies. With the Caliber/ Crowley Center alignment novel cancer therapies products can be developed and moved into a clinical setting at a very rapid and efficient pace.


Gradalis®, Inc.

Caliber Biotherapeutics has a strategic alliance with Gradalis®, Inc., for the development, manufacturing, and commercialization of drugs, vaccines and diagnostics primarily in the area of cancer.

Gradalis® is a vertically integrated biotechnology company committed to developing core technologies poised to deliver therapeutics that offer safer and more effective treatments for cancer. Gradalis®’ mission is to develop safe, personalized and highly effective cancer therapeutics in order to make a substantive impact on the treatment of the disease.


G-Con Manufacturing

Caliber Biotherapeutics has a strategic alignment with G-Con Manufacturing, in College Station, Texas for comprehensive GMP Manufacturing solutions.

G-Con's mission is to revolutionize the biomanufacturing industry by providing comprehensive GMP manufacturing solutions that are flexible, less expensive to build and maintain, and easier to operate than any existing solution.